Clik here to view.
Venture-Backed IPOs Recovering but Weak: We Compare Results for San...
Bruce V. Bigelow Amid an overall improvement in IPOs, a survey by Menlo Park, CA-based VentureDeal shows 21 venture-capital backed technology or life sciences companies went public in the U.S. during...
View ArticleClik here to view.
Codexis Morphs From Big Science Project Into $100M Business
Luke Timmerman Enzymes make the world go around, if you spend much time listening to biochemists. Now one of the emerging players in the business of engineering industrial enzymes, Redwood City,...
View ArticleClik here to view.
PacBio’s $200M IPO, Ablexis’ 5-Way Big Pharma Deal, Codexis Morphs Into $100M...
Luke Timmerman This week, the life sciences tool industry grabbed a rare opportunity to take the spotlight away from its better known counterpart the biopharmaceutical business. —Menlo Park, CA-based...
View ArticleClik here to view.
Northern California’s Top 5 Biotech Innovation News Stories
Gail Maderis The year that was 2010 was another year on the rollercoaster. We had our ups and our downs. But throughout, we continued to be at the forefront of innovation. From mature companies to...
View ArticleClik here to view.
Don’t Discount Biofuels
John Gardner As one who’s spent a lifetime chasing the quest of a practical, sustainable bioeconomy – I have sympathy for biofuel skeptics. Let’s face it; petroleum is an incumbent that has no match...
View ArticleClik here to view.
Codexis To Make Household Cleaners
Luke Timmerman Redwood City, CA-based Codexis (NASDAQ: CDXS), the maker of industrial enzymes from renewable sources, said today it has formed a collaboration with Italy-based Chemtex to develop...
View ArticleClik here to view.
Finding Trends: Cleantech IPOs Skew Toward Biofuels, Materials, Energy...
Bruce V. Bigelow Even before global markets reacted to the U.S. credit downgrade, IPOs for cleantech companies have been relatively few and far between. Still, the IPO data for the first half of 2011...
View ArticleClik here to view.
With a Push from Calysta, Biofuels Economy Tilts Toward Natural Gas
Bernadette Tansey Natural gas is best known to most people as a fuel burned to heat homes or generate electricity. Josh Silverman, chief scientific officer and co-founder of the Menlo Park startup...
View ArticleClik here to view.
The Road Not Taken and Genomatica’s Renewable Chemicals Strategy
Bruce V. Bigelow A few weeks ago, BP cancelled a $350 million project in Highlands County, FL, that was supposed to produce 36 million gallons of ethanol a year from “energy grasses” and other...
View ArticleClik here to view.
West Coast Biotech Roundup: Genentech, CareDx, and More
Alex Lash The week started amid anticipation of a new round of public debuts, with six of the 11 companies queued up coming from the life sciences, according to Renaissance Capital. Then on Tuesday,...
View ArticleClik here to view.
MyoKardia, Sanofi Ink $200M+ Deal for Targeted Heart Drugs
Ben Fidler Third Rock Ventures started up MyoKardia in 2012 around the idea of making genetically targeted drugs for certain forms of heart disease. Two years and $38 million in venture funding into...
View Article
